KrisVKowdleyMDFACP,FACG,FASGE,AGAF
Gastroenterology • Seattle, WAHepatology & Liver Transplantation
Director, Liver Care Network Swedish
Dr. Kowdley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3216 NE 45th Pl
Ste 212
Seattle, WA 98105Phone+1 206-536-3030Fax+1 206-524-0749
Education & Training
Tufts Medical CenterFellowship, Gastroenterology, 1989 - 1991
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1986 - 1988- Oregon Health & Science University (OHSU Health)Internship, Internal Medicine, 1985 - 1986
Icahn School of Medicine at Mount SinaiClass of 1985
Certifications & Licensure
OR State Medical License 1986 - Present
WA State Medical License 1993 - 2026
OH State Medical License 1991 - 1994- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification HealthSentry EHR, Cerner Corporation, 2013
- Elected Member The American Society for Clinical Investigation, 2006
- Join now to see all
Clinical Trials
- IdB 1016 Treatment for Hepatitis C Disease Start of enrollment: 2003 Nov 01
- Iron Depletion Therapy for Type 2 DM and NAFLD Start of enrollment: 2005 Sep 01
- Effect of Omega-3 PUFA Supplementation in NAFLD Patients Start of enrollment: 2005 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 323 citationsLevels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: An international follow-up studyWillem J Lammers, Henk R. van Buuren, Gideon M. Hirschfield, Harry L.A. Janssen, Pietro Invernizzi
Gastroenterology. 2014-12-01 - 131 citationsUrsodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitisMaren H. Harms, Henk R. van Buuren, Christophe Corpechot, Douglas Thorburn, Harry L.A. Janssen
Journal of Hepatology. 2019-08-01 - 64 citationsFibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response.Carla F. Murillo Perez, Gideon M. Hirschfield, Christophe Corpechot, Annarosa Floreani, Marlyn J. Mayo
Alimentary Pharmacology & Therapeutics. 2019-11-01
Journal Articles
- Diagnosis and Management of Primary Biliary CholangitisZobair M Younossi, Kris V Kowdley, Ira M Jacobson, Mitchell L Shiffman, Paul Kwo, Nature
Other
- Treatment of primary sclerosing cholangitisKowdley KV
http://www.uptodate.com/contents/treatment-of-primary-sclerosing-cholangitis
UpToDate, Wolters Kluwer Health - 2013-02-26 - Clinical manifestations and diagnosis of primary sclerosing cholangitisKowdley KV
http://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-primary-sclerosing-cholang
UpToDate, Wolters Kluwer Health - 2013-01-28 - Recurrent pyogenic cholangitisKowdley KV, Lee H
http://www.uptodate.com/contents/recurrent-pyogenic-cholangitis
UpToDate, Wolters Kluwer Health - 2012-11-28 - Join now to see all
Press Mentions
Findings from COBALT Trial, Including External Control Arm, Published in the American Journal of GastroenterologySeptember 6th, 2024- CymaBay Reports Third Quarter and Nine Months Ended September 30, 2022 Financial Results and Provides Corporate UpdateNovember 14th, 2022
- Mirum Pharmaceuticals to Showcase LIVMARLI® (Maralixibat) Data at EASL and ESPGHAN Annual CongressesJune 13th, 2022
- Join now to see all
Professional Memberships
- Fellow
- Fellow
- Fellow
- American Association for the Study of Liver Disease - AASLDFellow
Other Languages
- Tamil
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
